Catrin Jackson
Catrin is TOPRA's Content Writer. She is responsible for editing and proofreading content for Regulatory Rapporteur, TOPRA's monthly peer-reviewed journal. In addition to writing content for a range of projects, she also composes TOPRA's monthly membership newsletter, InTouch.
Industry newsParkinson’s drug slows progression of motor symptoms
A developmental drug has shown promise in slowing symptoms of motor deterioration in people with advanced forms of Parkinson’s.
Industry newsNovel antibiotic receives EMA’s recommendation
The European Medicines Agency has recommended marketing authorisation for an antibiotic which can treat multidrug-resistant infections.
Industry newsModified skin bacteria treats tumours in mice
A study from Stanford Medicine has developed a promising method to treat cancer using a type of bacteria which is found on skin.
Industry newsCutting antibiotic usage reduces resistance levels
Cutting the use of antibiotics in both humans and animals has shown a reduction in antimicrobial-resistant bacteria.
Industry newsUtah law to permit non-FDA-approved stem cell therapies
Utah has passed legislation that will allow patients to receive placental stem cell therapies without the need for FDA approval.
Industry newsCholera vaccine shortage puts millions at risk
The World Health Organization has declared a worldwide shortage of the oral cholera vaccine amid an upsurge in cases.
Industry newsRadio waves used to hijack E.coli bacteria to make medicines
Researchers have developed a method that uses high-frequency radio waves to temporarily open bacterial cell walls to introduce new DNA.
Industry newsSponge-on-a-string cuts wait time for Barrett’s diagnosis
A procedure to test for a precancerous condition of the oesophagus, which uses a novel medical device, is under trial in NHS England.
Industry newsMHRA reclassifies codeine linctus as prescription-only
Over-the-counter cough syrups which contain the opioid codeine have been reclassified as prescription-only medicines due to the risk of abuse.
Industry newsViolin resin works as cleaning agent for ‘superbugs’
A form of resin taken from a Norway spruce has been found to also function as an effective disinfectant against drug-resistant bacteria.
Industry newsAngioedemas caused by rare gene fault curable by CRISPR
A single dose of a CRISPR gene therapy has been shown to almost eliminate a rare genetic, inflammatory and potentially life-threatening condition.
Industry newsEMA platform to monitor use of antimicrobials
All EU member states are required to submit data on sales and use of antimicrobials in animals to the EMA’s new platform.
Industry newsNHS Pharmacy First offers an alternative to GPs in England
Pharmacists in England can now provide treatment for seven common health conditions without patients first consulting a doctor.
Industry newsAUS-UK joint agency vetmed approval process agreed
The UK’s VMD and Australia’s APVMA have published guidance for the simultaneous review of veterinary medicines submissions.
Industry newsDisposable vapes set to be banned in Britain by 2025
UK Prime Minister Rishi Sunak has announced a ban on disposable vapes, expected to be enforced in England, Wales and Scotland from 2025.
Industry news£34m NIHR funding open to researchers from LMICs and UK
The NIHR has announced a new award to help create career opportunities for researchers from low-and middle-income countries and the UK.
Industry newsNon-surgical gastric balloon to be made available on NHS
A novel gastric ‘balloon’ medical device has been made available on the UK’s National Health Service (NHS) for the first time.
Industry newsMHRA tightens restrictions on fluoroquinolones
The UK’s MHRA has announced that fluoroquinolone antibiotics can only be prescribed when no other antibiotic is appropriate.
Industry newsDevice which can detect skin cancer approved by FDA
The FDA has approved a wireless hand-held device that uses an artificial intelligence-powered algorithm to detect skin cancer.
Industry newsMHRA workplan to support safe access to medtech
The MHRA has published a two-year workplan which will see the introduction of a range of new regulations for medical devices in the UK.